SecBot SecBot

Diabetes Act

S. 5502 Sen. Jeanne Shaheen (D-NH) In committee
  1. Introduced Dec 12
  2. Committee Dec 12
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Dec 12, 2024Next: Senate vote
685d ago Dec 12, 2024: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
1company, 1 filing
Member trades
5trades in the last 90 days
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

1 company
Companies by sector
Medical Devices & Healthcare 1
Search all 1 companies, their asks and price moves Subscribe

Summary

This bill ensures continued access to diabetes technology when individuals enroll in Medicare, and expands related training and education services. It amends the Social Security Act to require care continuity for diabetes technology, expand self-management training, create new billing codes for insulin pump training, and mandate reports on access barriers.

Sec. 3, Continued access to diabetes technologies: During the first 12 months of Medicare Part B enrollment, a provider can certify that an individual is using diabetes technology covered under Part B. The Secretary must issue a certification form by January 1, 2026, and develop a process to consider coverage for technologies not currently covered. This applies to items and services furnished on or after January 1, 2026.

Sec. 4, Expanding access to diabetes outpatient self-management training: Amends the definition of diabetes outpatient self-management training to allow qualified non-physician practitioners to provide and refer for services, and removes limits on the quantity or duration of training if deemed medically necessary. Applies to items and services furnished on or after January 1, 2026.

Sec. 5, Providing insulin pump training and education: By January 1, 2026, the Secretary must establish new billing codes for insulin pump hook-up, calibration, and patient training, similar to existing codes. The Secretary must also educate stakeholders on billing for these codes.

Sec. 6, National coverage determination on insulin pumps: Within 180 days of enactment, the Secretary must issue a proposed national coverage determination for insulin pumps (continuous subcutaneous insulin infusion).

Sec. 7, Report on enrollee access to diabetes-related services and technologies: Within one year, the Comptroller General must report to Congress on barriers to accessing diabetes technologies and self-management education across federal health care programs, including prior authorization, formulary restrictions, and coverage limits.

Summary of the bill text as introduced in Senate (Dec 12, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.